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Sequential renal biopsies in insulin.dependent diabetic patients: Struc-
tural factors associated with clinical progression. Quantitative structural
studies in native kidneys of IDDM patients have almost all been cross
sectional, and little is known regarding the dynamics of progression of
structural lesions in relation to clinical progression. It has been suggested
that interstitial may be more important than glomerular changes in
determining functional outcome. This study evaluated renal structure in
sequential biopsies from IDDM patients with established renal lesions to
determine whether glomerular, arteriolar and interstitial changes progress
together and in concordance with measures of renal function. Eleven
long-term IDDM patients [age 29 10years, duration 17 7 years (mean
sD)I had renal function studies and kidney biopsies performed at two
occasions 5.6 1.6 years apart. HbA1 as well as creatinine clearance (Car)
did not change over this time; albumin excretion rate (AER) increased
from 12 (6 to 280) to 19 (5 to 2462) [median (range)] mg124 hr (P < 0.03).
AER increased in the three patients with abnormal albuminuria at first
observation, and two normoalbuminuric patients became microalbumin-
uric. Blood pressure (BP) did not change; however, the number of patients
on antihypertensive therapy increased from 1 to 5. All structural param-
eters were abnormal at first evaluation. Mesangial fractional volume
[Vv(mes/glom)] and mean glomerular volume increased and the surface
density of the peripheral glomerular basement membrane (GBM) de-
creased, while GBM width did not change over the five years of the study.
Also, arteriolar hyalinosis lesions progressed, while the fractional volume
of cortical interstitium [Vv(interstitium/cortex)} and the percent of glo-
bally sclerosed glomeruli did not change. The only structural change that
correlated with the increasing AER was the change in Vv(mes/glom).
Changes in structural parameters, AER or Cr did not significantly
correlate with baseline BP or change in BP over the five years. Although
based on a small number of patients, this study suggests that at the stage
of disease where renal lesions are established and where some IDDM
patients are in transition to microalbuminuria or early clinical nephropa-
thy, continuing mesangial expansion is the central variable. Interstitial
changes were not occurring over this time. Progressive interstitial expan-
sion at the later stages of diabetic nephropathy may thus be consequent to
advanced diabetic glomerular injury.
Long-standing type I insulin-dependent diabetes mellitus
(IDDM) results, in approximately 25% of patients, in a constel-
lation of renal lesions which culminates in overt renal disease
progressing to renal insufficiency. This decline in glomerular
filtration rate (GFR) as well as proteinuria and hypertension are
correlated with a number of renal structural abnormalities, includ-
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ing increased mesangial fractional volume {Vv(mes/glom)], de-
creased glomerular filtration surface, interstitial expansion, arte-
riolar hyalinosis and increased numbers of globally sclerotic
glomeruli [1—7]. However, since mesangial and interstitial expan-
sion [3], as well as arteriolar hyalinosis and global glomerular
sclerosis [41 tend to co-correlate, it has been difficult to determine
from cross sectional studies if one of these abnormalities is more
closely related to progressive renal functional deterioration in
diabetic nephropathy. Further, there are no longitudinal studies
with careful measures of glomerular, interstitial and vascular
structure and renal function in patients with longstanding IDDM.
Such studies are described in the present report. In a five year
study, we found that increasing mesangial fractional volume was
closely linked to the development of microalbuminuria and early
overt nephropathy, while interstitial expansion and global glomer-
ular sclerosis did not progress over this time. Additionally, the
structural changes of diabetic nephropathy were progressive, even
in patients with stable renal function.
Methods
Patients
Eleven IDDM patients (1 male, 10 females; age 29 10 years;
duration of IDDM 17 7 years) had renal function studies and
kidney biopsies as part of their evaluation as possible candidates
for pancreas transplantation. All patients spent one week in the
Clinical Research Center (CRC) at the University of Minnesota
for pre-pancreas transplant evaluation, during which they under-
went multiple 24-hour urine collections (at least 3) for measure-
ments of creatinine clearance (Car) and urinary albumin excretion
rate (AER). Blood pressure (BP) was measured repeatedly by the
CRC nursing staff. HbA1 was used to assess glycemic control. All
patients underwent percutaneous kidney biopsy.
Seven patients never received a pancreas transplant; four
received a pancreatic graft that failed within six weeks. These
patients, still diabetic and receiving insulin therapy, volunteered
to have renal function studies and kidney biopsies repeated 5.6
1.6 (2.8 to 7.5) years after the first evaluation. Some of the
structural parameters of 10 of these patients have been reported
in studies focused on the effects of pancreas transplantation and
cyclosporine therapy on renal structure, where the patients in the
current studies served as controls [8, 9].
Sixty-one kidney transplant donors (29 males, 32 females; age
29 8 years), matched for age with the group of IDDM patients,
served as normal control subjects for the structural data.
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Procedures
These studies were approved by the Committee for the Use of
Human Subjects in Research of the University of Minnesota; all
patients gave written informed consent before each study. HbA1
was measured by BioRad column assay until November 1986 and
by HPLC thereafter (BioRad Diamat, Biorad Laboratories, Her-
cules, CA, USA). In some of the patients studied in the early
1980's, only total glycosylated hemoglobin was initially measured;
therefore in all patients, the values are expressed as total HbA1
(normal range 5.4—7.9%). Serum and urine creatinine levels were
measured by an automated kinetic method that uses the Jaffe
reaction. AER was measured by nephelometry using the Beckman
kit (Beckman Instruments, Inc., Fullerton, CA, USA; normal
values 22 mg/24 hr).
Renal tissue was obtained by percutaneous biopsy and pro-
cessed for light and electron microscopy [10]. Morphometric
measurements were performed by a single observer (PF), unaware
of the patients' identities.
Electron microscopic examination was carried out on tissue
fixed in 2.5% glutaraldehyde in Millonig buffer and embedded in
Polybed 812. Globally sclerotic glomeruli were excluded. Four
glomeruli were analyzed from each biopsy, except for four biop-
sies, where only three glomeruli were available. Ultrathin sections
were obtained and examined with a JEOL 100CX electron
microscope (JEOL, Tokyo, Japan). Glomeruli were photographed
to obtain a final magnification of x3900 to produce photomon-
tages of the entire glomerular profile, defined as the circum-
scribed, minimal convex polygon enclosing the glomerular tuft [8,
11—13]. The montages were used to estimate Vv(mes/glom) and
surface density of the peripheral glomerular basement membrane
(GBM) [Sv(PGBM/glom)j, superimposing a double lattice square
grid with equally spaced coarse points 60 mm apart, and equally
spaced fine points 30 mm apart, so that each coarse point defined
4 fine points. The grid also comprised 30 mm lines. Vv(mes/glom)
was estimated by counting the number of fine points falling on
mesangium (PM) (including its matrix and cellular components
and the GBM lying between the epithelial cells and the mesan-
gium) in relation to the number of coarse points counted to
determine points hitting the glomerular tuft (PG). Since each
coarse point defined 4 fine points, then
PM
Vv(mes/glom) =
PG X 4(/tm3I/Lm3)
The normal value in the controls for Vv(mes!glom) was 0.20
0.03; the coefficient of variation among the glomeruli in the
patients presented here was on average 15%. Sv(PGBM/glom)
was determined by counting intercepts (I) between the grid lines
and the epithelial/peripheral GBM interface, using the formula
I 2X1
Sv(PGBMJg1om) =2 x — =
. . 1irn/prn3L 60000 magnification X PG
Where I!L= number of intercepts divided by the length of the grid
lines overlying the reference space, the glomerular tuft. In order
to overcome orientation problems, the measurements were per-
formed a second time after rotating the grid 90°. Thus the
estimate of Sv(PGBM/glom) represents the mean of the two
measurements. The normal value in the controls for Sv(PGBM/
glom) was 0.127 0.017 .tm2!m3; the coefficient of variation
among glomeruli in the patients presented here was on average
18%. Another set of micrographs, photographed to obtain a final
magnification of x 12,000 by entering the glomerulus at its lowest
segment and systematically sampling about 20% of the glomerular
profile (from 4 glomeruli), was used to estimate GBM width by
the orthogonal intercept method [14]. The measurements were
made at each point that a line of the grid intercepted an
endothelial/peripheral GBM interface. GBM width was measured
on a line orthogonal to the edge of the peripheral GBM at the
endothelial side of the intercept. The number of measurements
performed in each biopsy to estimate GBM width was 151 42.
The normal value in the controls was 340 46 nm; the coefficient
of variation among the glomeruli in the patients presented here
was on average 10%. Vv mesangial matrix per glomerulus and
mesangial cell per glomerulus were estimated by the point count-
ing technique on the high magnification photographs [15]. Points
falling on mesangial cell (MC), mesangial matrix (MM), and
mesangial GBM (MGBM) were noted. Calculations are as fol-
lows:
MC
Vv(MC/mesangium) = MC + MM + MGBM
MM
Vv(MM/mesangium) = MC + MM + MGBM
Vv(MC/glom) = Vv(MC/mesangium) X Vv(mes/glom)
Vv(MMlglom) = Vv(MM/mesangium) X Vv(mes/glom)
Tissue for light microscopy was embedded in paraffin, cut in 2 to
3 m sections and stained with periodic acid-Shiff stain (PAS).
Mean glomerular tuft volume (MGV) was estimated as previously
described [16] when at least 20 glomerular profiles were available.
Glomerular tuft profiles were measured in two sections 120 m
apart. The fractional volume of the renal cortex which is intersti-
tium [Vv(interstitium/cortex)] was estimated using a projecting
microscope at a magnification of x300 [3, 91. All available cortical
tissue was measured. Points falling on the interstitium, defined as
the space outside Bowman's capsule, tubular basement membrane
and vessels larger than one tubular diameter, and total number of
points overlying the cortical tissue were counted to estimate the
Vv(Interstitium/cortex), using a 1:4 grid with a distance between
fine points of 13 mm (normal value: 0.15 0.02).
Percent sclerosed glomeruli was determined, as previously
described, only when at least 20 glomeruli were available for study
also (normal value < 10%) [4].
The arteriolar hyalinosis score was obtained by grading as 0
normal arterioles, as 1.0 vessels with less than 50% (<50%) of the
arteriolar wall replaced by hyaline material and as 2.0 vessels with
more than 50% (>50%) of the arteriolar wall replaced by hyaline
material. The sum of these scores was then divided by the number
of the arterioles evaluated.
Arteriolar hyalinosis score = —
where n = number of arterioles.
(lXn <50%)+(2Xn >50%)
total number of arterioles
Statistical analysis
Data are expressed as mean 1 SD, except for AER, where the
median is given. Values for AER, because they were not normally
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Patient
number'
Age years,
Gender
IDDM
duration
years
Hb Al %
Baseline Follow-up
1 22, F 10 13.9 15.8
2 26, F 7 8.9 10.2
3 32, F 27 13.2 11.7
4 44, F 22 10.5 12.8
5 24, F 14 11.4 13.4
6 26, F 12 12.2 9.5
7 48, M 27 8.2 10.1
8 25, F 15 11.8 12.1
9 22, F 16 11.8 9.9
10 39, F 23 12.6 13.8
11 14, F 13 13.4 13.2
Mean SD 29 10 17 7 11.6 1.8 12 2
P value NS
Albumin Creatinine Mean
excretion rate clearance blood pressure
Patient mg/24 hr mi/minll. 73 m2 mm Hg —
numbera Baseline Follow-up Baseline Follow-up Baseline Follow-up
1 NA 19 101 129 84 88
2 6 15 108 115 78 89
3 6 67 86 62 83 76
4 8 87 74 59 84 88h
5 10 13 130 116 79 78
6 10 14 88 91 78 79"
7 12 5 129 114 86 82
8 22 15 73 56 85 88
9 68 1200 85 83 92 90"
10 242 2462 101 83 86" 79h
11 280 613 86 73 95 97h
Mean 96 20 89 26 84.5 5.4 84.9 6.5
SD
Median 12 19
P value <0.03 NS NS
distributed, were logarithmically transformed before analysis.
Comparisons between the diabetic group and the control group
were performed using Student's t-tests for unpaired data. Com-
parisons between baseline and follow-up data in IDDM patients
were performed using paired t-tests. The relationships between
functional and structural parameters were analyzed by regression
analysis. Values for P < 0.05 were considered significant.
Results
The clinical features of these 11 patients are summarized in
Tables I and 2. HbA1 did not change over five years (11.6 1.8%
and 12,0 2%, ns). AER significantly increased (P < 0.03) during
the study (Fig. 1, Table 2). AER was abnormal in 3 of 11 patients
at baseline; in these three patients AER increased over five years.
Two normoalbuminuric patients became microalbuminuric at
follow-up. Cr (Table 2) did not change over five years (96 20
vs. 89 26 ml/min/1.73 m2, NS). Mean blood pressure did not
change; however, the number of patients on antihypertensive
treatment increased from 1 to 5. Four of the five patients with
abnormal AER at follow-up were treated for hypertension (Table
Electron microscopy studies
Compared with control subjects, the baseline mean values for
GBM width (P < 0.0001) and Vv(mes!glom) (P < 0.0001) were
increased, and those for Sv(PGBM/glom) (P < 0.0001) were
reduced (Table 3).
GBM width, abnormal at baseline in 9 of 11 patients, did not
change over five years in this group of patients (Table 3); however,
in four of the five patients with increasing AER there was a slight
increase in GBM width.
Vv(mes/glom), abnormal at baseline in 9 of ii patients, in-
creased over five years (P < 0.008; Table 3). Sv(PGBM/glom)
decreased from baseline to follow-up (P < 0.05; Table 3).
Vv(MC/glom) increased significantly during the five years (from
0.09 0.03 to 0.12 0.04, P < 0.0001), as did Vv(MM/glom)
(from 0.17 0.04 to 0.21 0.06, P < 0.004). The ratio between
mesangial matrix and cells per glomerulus, abnormal at baseline
(normal value I 0.015) did not change (from 1.86 0.39 to 1.73
0.23, NS), suggesting that the two mesangial components
increased in parallel. The change in Vv(mes/glom) or changes in
other structural parameters during the five years did not correlate
significantly with baseline mean blood pressure or change in mean
blood pressure over five years. However, hypertension was aggres-
sively treated in these patients after the initial biopsy. Also,
Table 1. Clinical characteristics
U Listed in order of increasing baseline AER
Abbreviations are: IDDM, insulin-dependent diabetes; Hb Al, hemo-
globin Al.
Table 2. Renal function
10,000
1,000
100
10
Follow-up
Fig. 1. Albumin excretion rate (AER) at baseline and five years follow-up.
Values (logarithmically transformed prior to analysis) increased signifi-
cantly over this time (P < 0.03). AER values were not available at baseline
in patient number 1.
Baseline
U Listed in order of increasing baseline AER
h On antihypertensive therapy
2).
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Table 3. Electron microscopic morphometric analysis
Patient
number
GBM width
nm Vv(mes/glom)
Sv(PGBM/glom)
pm2/pm3
Baseline Follow-upBaseline Follow-up Baseline Follow-up
1 710 680 0.21 0.28 0.122 0.112
2 346 407 0.26 0.24 0.141 0.126
3 543 493 0.30 0.33 0.121 0.106
4 476 503 0.38 0.43 0.098 0.085
5 622 756 0.25 0.35 0.117 0.085
6 789 667 0.29 0.38 0.092 0.073
7 377 317 0.26 0.28 0.133 0.160
8 498 572 0.32 0.36 0.105 0.081
9 765 821 0.41 0.61 0.097 0.046
10 646 673 0.31 0.46 0.071 0.058
11 642 705 0.32 0.39 0.083 0.093
Mean so 584 147 602 153 0.31 0.06 0.37 0.10 0.107 0.02 0.093 0.03
P value NS <0.008 <0.05
a Listed in order of increasing baseline AER
Abbreviations are: GBM, glomerular basement membrane; Vv(mes/glom), mesangial fractional volume; Sv(PGBM/glom), surface density of the
peripheral GBM.
Table 4. Light microscopic morphometric analysis
Patient
MGV
(X 106/Lm3) Vv(int/cortex)
% Sclerosed
glomeruli
Arteriolar
hyalinosis scores
Baseline Follow-upBaseline Follow-upBaseline Follow-upnumber' Baseline Follow-up
1 1.50 1.72 0.23 0.25 0 0 25 68
2 0.93 1.47 0.22 0.20 0 0 21 41
3 1.27 1.49 0.22 0.23 3 2 46 51
4 2.23 1.60 0.24 0.24 14 21 74 150
5 1.54 2.19 0.24 0.25 0 0 38 35
6 2.20 2.95 0.25 0.21 1 0 32 50
7 1.45 1.93 0.30 0.28 11 17 34 41
8 1.05 1.81 0.26 0.26 24 44 24 44
9 2.01 2.00 0.29 0.28 8 50 54 52
10 1.70 3.30 0.27 0.28 15 10 23 86
11 1.44 1.77 0.25 0.25 0 9 33 43
Mean so 1.57 0.43 2.02 0.59 0.25 0.03 0.25 0.03 6.9 8.2 13.9 17.9 36.7 16.0 60.1 33.1
P value 0.02 NS NS 0.01
a Listed in order of increasing baseline AER.
Abbreviations are: MGV, mean glomerular volume; Vv(int/cortex), cortical interstitial fractional volume.
baseline Cc or change in Ccr over the five years did not correlate
with change in any of the structural parameters.
Light microscopy studies
MGV was increased at baseline in 4 of 11 patients and
increased over five years (P < 0.03; Table 4) in the group as a
whole. As a consequence of the increased Vv(mes/glom) and
MGV, total mesangium/glomerulus increased over five years
(from 0.49 0.20 to 0.78 0.36 X 106 m3, P < 0.009). Total
surface/glomerulus stayed stable (0.17 0.04 and 0.18 0.05 X
106 jtm2, NS), this the result of the decreased Sv(PGBM/glom)
and of the increased MGV.
Vv(interstitium/cortex) was significantly increased at first ob-
servation, with all the patients being higher than the normal range
(Table 4), and did not change in five years. The measures of
Vv(interstitium/cortex) in the baseline and five years biopsies
were highly correlated (r = 0.79, P < 0.005).
The number of globally sclerosed glomeruli did not change in
five years (Table 4). The arteriolar hyalinosis score, abnormal in
all patients at baseline, was significantly increased at follow-up
(P < 0.01; Table 4).
AER and structural and functional changes
The change in AER over time correlated with the change in
Vv(mes/glom) over the same interval (r = 0.64, P < 0.05; Fig. 2);
no other structural parameter correlated with the change in AER.
The change in AER over five years was not significantly correlated
with baseline values or with change over five years in mean BP or
Ccr.
Discussion
Previous studies of renal structural-functional relationships in
IDDM patients have largely been cross-sectional [1—7, 11]. Sev-
eral structural changes including the increases in Vv(mes/glom),
Vv(interstitium/cortex) and % global glomerular sclerosis have
been shown to be inversely related to GFR and directly related to
albuminuria and blood pressure. There is a tendency, in IDDM
patients, for these structural lesions to develop in parallel [1, 3, 4J.
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Fig. 2. Correlation between the changes in Vv(mes/glom) and in albumin
excretion rate (AER) over five years fr = 0.642, P < 0.05). AER values were
not available at baseline in patient number 1.
Thus it is not possible from cross sectional studies to determine
which lesion is more closely related to clinical progression. Taft et
al [17] studied 19 IDDM and non-insulin-dependent (NIDDM)
diabetic patients with overt nephropathy and hypertension with
two renal biopsies performed four years apart. They reported that
the decline in Cr over that time was inversely related to the
change in a measure of interstitial fibrosis. There was also an
increase in % global glomerular sclerosis between the first and the
second biopsies, which was not correlated with the change in Cr
[17]. However, electron microscopic morphometric measures of
diabetic glomerular structural parameters were not performed.
Bader et al [18], in cross-sectional studies, also claimed that the
interstitial changes in diabetic patients were more closely related
to functional disturbance than glomerular changes, but again,
careful glomerular structural measures were not done.
Bangstad et al [19] performed two biopsies at 26 to 34 months
intervals in nine microalbuminuric patients with mean IDDM
duration of 11.2 years who were under standard glycemic control.
They found no change in Vv(mes/glom) or in Vv(MM/glom),
while mesangial matrix increased only as a fraction of mesangial
volume. Also GBM thickness increased over this time. As in some
patients in the present study, these changes were not accompanied
by increases in AER or BP, or decreases in GFR. This is not
surprising since lesions of diabetic nephropathy can be developing
in IDDM patients with normal AER [11, 20] and since the time
interval of this study was relatively brief [191. Interstitial and
vascular lesions were not evaluated in the study of Bangstad et al
[19].
Yamuchi et al [211 performed repeat qualitative light micro-
scopic renal biopsy studies after an interval of one to five years in
11 IDDM and NIDDM patients with 1.5 to 6.5 years of known
diabetes duration [211. They concluded that mesangial expansion
was progressive between the biopsies, although all but three
patients remained clinically stable in terms of proteinuria, GFR
and BP.
Our studies are unique in the long duration of IDDM at
baseline, the long interval of approximately five years between
renal biopsies, the broad range of baseline AER and Cr values in
the group, and the relatively large proportion of patients in
transition towards more severe clinical renal disease categories.
The most consistent glomerular structural change from baseline
to follow-up was increase in Vv(mes/glom) and glomerular vol-
ume. Also there was progression in arteriolar hyalinosis lesions.
There was no change in interstitial volume fraction, GBM width,
or % global glomerular sclerosis. The only structural parameter
change correlating with the increase in AER over five years was
the increase in mesangial fractional volume. This is consistent
with hypotheses generated from cross sectional observations [1,
11].
Although based on a small number of patients, these results
indicate that progressive glomerular, rather than interstitial
changes, are associated with clinical transition in IDDM. In fact,
since there was no change in the interstitium over the five years of
these studies, these results support the idea that advanced inter-
stitial expansion in IDDM may be secondary to progressive and
advanced glomerular and vascular lesions.
It is unlikely that these findings resulted from a relative
insensitivity of our measurements of interstitial as compared to
glomerular structural parameters. Firstly, the baseline and five
years values for Vv(interstitium/cortex) were highly correlated. If
the method was imprecise, we would not have expected such a
close correlation between the two biopsies from the same patient,
particularly given the narrow range for Vv(interstitium/cortex)
values in this study. Secondly, we were able to measure changes in
Vv(interstitium/cortex) in five years in IDDM patients on cyclo-
sporine (CsA) which were highly correlated with changes in CCr
and CsA dose and blood levels [9]. Not disputed here is the
concept that proteinuria from glomerular alterations could lead to
interstitial injury and further renal structural and functional
deterioration [22]. However, such mechanisms are more likely to
operate at later stages of diabetic nephropathy, particularly when
there is increasing global glomerular sclerosis [3, 4].
The mechanism by which increased mesangial fractional vol-
ume could lead to increasing albuminuria is not known. One
possibility is that mesangial interposition into the subendothelial
space may change permselectivity characteristics of the glomeru-
lar capillary wall [12, 23]. Also progressive mesangial expansion is
associated with compositional changes such as decreased density
of the al(IV) and a2(IV) collagen chains in the area of the lamina
rara interna of the GBM [24, 25]. Careful studies of the glomer-
ular capillary wall expression of other extracellular matrix mole-
cules such as type VI collagen and various proteoglycan molecules
remain to be done, but charge site density in the lamina rara
interna, reflecting heparan sulphate proteoglycans, is decreased in
proteinuric IDDM patients [26]. Such alterations in glomerular
capillary wall molecular composition could explain altered protein
permselectivity. GBM width did not increase over five years in
these patients as a group; however, since GBM width increased in
0.00 0.10 0.20
Vv, mes/glom
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four of five patients in clinical transition, a role for this structural
change per se as contributing to albuminuria cannot be excluded.
The surface density of the peripheral GBM [Sv(PGBM/glom)j
decreased over five years but, offset by an increase in mean
glomerular volume, filtration surface per glomerulus did not
change. Consistent with this finding was the stable Cr, since
filtration surface per glomerulus and GFR are closely related in
IDDM patients [5—7]. However we cannot exclude that changes in
glomerular capillary architecture, as suggested by the reduced
Sv(PGBM/glom) are associated with glomerular hemodynamic
perturbations. Thus it is possible that mesangial expansion, with
the consequent reduction in Sv(PGBM/glom), initiates hemody-
namic changes which alter glomerular permeability. However,
when we examined the relationships between changes in albumin-
uria and in structural parameters over time, the only significant
correlation was with the change in Vv(mes/glom).
Arteriolar hyalinosis is frequently observed in IDDM patients
[4, 27], involves both afferent and efferent glomerular arterioles
and is related to the percent of global glomerular sclerosis in
long-standing IDDM patients [4]. Sequential biopsies of renal
allografts in IDDM patients documented that the early progres-
sion of arteriolar hyalinosis was related to glycemic control [28].
However, longitudinal studies in native kidneys of IDDM patients
have not been previously done. Arteriolar lesions also progressed
during this study, but there was no significant relationship of this
progression to the emergence of early clinical diabetic renal
disease. Arteriolar hyalinosis, however, is associated with an
increased frequency of global glomerular sclerosis only when
these vascular lesions are far advanced [I. Thus, these progres-
sive vascular lesions may be of greater importance at later stages
of disease than studied here.
A considerable body of information exists supporting the view
that antihypertensive treatment can slow clinical progression of
renal disease in diabetic patients with microalbuminuria or overt
nephropathy [29, 30]. Although this study did not find significant
correlations between baseline blood pressure or change in blood
pressure over five years and changes in AER or structure, such
relationships might emerge with larger numbers of patients or
with patients treated less aggressively for hypertension during the
interval between renal biopsies.
In summary, this work leads towards the conclusion that
glomerular, especially mesangial, structural changes are impor-
tant in the clinical transition to microalbuminuria and increasing
proteinuria in IDDM patients, while interstitial lesions do not
seem to have a pathogenetic role at this stage of the disease.
However the mechanism of clinical progression remains poorly
understood. Clearly there is a need for more serial renal biopsy
studies and for innovations in methodologies to explore renal
structural and functional changes in diabetes.
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